2
Registered trials
2
Recruiting
2
Unique sponsors
4
Unique IMPs
1
Commercial trials
Drug classes (ATC)
G
Urology/Gynaecology (ATC G)
1
J
Anti-infectives (ATC J)
1
—
ATC code not specified
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
3 substances
Azole antifungal
1 substance
Phase III:
1
Phase I/II:
1
Phase III
1 trial-
RecruitingMicurx Pharmaceuticals Inc. CommercialCONTEZOLID; LINEZOLID; METRONIDAZOLE; SODIUM O-ACETYL-(R)-ISOXAZOL-3-YL((2-OXO-3-(2,3,5-TRIFLUORO-4-(4-OXO-3,4-DIHYDROPYRIDIN-1(2H)-YL)PHENYL)OXAZOLIDIN-5-YL)METHYL)PHOSPHORAMIDATE
Phase I/II
1 trial-
RecruitingCentre Hospitalier Universitaire De Nantes AcademicIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Micurx Pharmaceuticals Inc. | Commercial | 1 | Phase III | 1 |
| Centre Hospitalier Universitaire De Nantes | Academic | 1 | Phase I/II | 1 |
New trials by year
2023
1
2024
1